Fulyzaq is designed to treat diarrhea in patients taking HIV and AIDS drugs.
Stories Related to Company: Fda Approved Diarrhea Drug
USATODAY.com Feed, USA Today
Wed, 01/02/2013 - 4:51am
RELATED ARTICLES
- Cancer Physicians Attack High Drug Costs
More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More - Swedish police find drugs on Bieber tour bus
The latest chapter in Justin Bieber's European tour escapade was added Thursday when Swedish police said they had found drugs and a stun gun on the pop singer's bus. Lars Bystrom, spokesman for the Stockholm police, told The Associated Press a small amount of drugs and a stun gun were discovered during a search of the bus, which had been parked under the Globen concert venue in Stockholm, where Bieber was performing Wednesday. More - AIDS Vaccine Path Suggested by Study
By tracking one patient’s immune response, scientists have tracked how a series of mutations led to an antibody that can defeat many H.I.V. strains. More - New FDA research finds 12% of retail chicken has salmonella, 74% of which is antibiotic-resistant
Perhaps, like me, you’ve wondered what percentage of retail meat has foodborne pathogens, and of those, which pathogens are antibiotic resistant. Well, you’re in luck. The Food and Drug Administration’s National Antimicrobial Resistance Monitoring System puts out a yearly report looking at the rates of antibiotic resistance of foodborne pathogens in retail meat and poultry samples. More - HIV Test Urged for 7,000 Oklahoma Dental Patients
Health officials are urging 7,000 patients of an Oklahoma dentist to seek medical tests to ensure they haven't been exposed to hepatitis or the virus that causes AIDS. The Oklahoma and Tulsa health departments say the patients may have been exposed to viruses at clinics operated by W. More
BING NEWS:
- FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated,...
GlobeNewswire, Health, Pharmaceuticals & Biotechnology, Product / Services Announcement | Ziihera is the first and only dual HER2-targeted bispecific ...
11/21/2024 - 12:28 am | View Link - US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version of Canada-based Bausch Health's blockbuster diarrhea drug Xifaxan.
11/18/2024 - 3:36 am | View Link - Nilotinib Without Mealtime Restrictions Gets Approved for Ph+ CML
Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...
11/15/2024 - 8:23 am | View Link - FDA approves renewal for canine chemotherapy-induced diarrhea treatment
Jaguar Health announced that its product, cofelemer delayed-release tablets (Canalevia-CA1; Jaguar Health), received approved renewal from the FDA. This oral tablet that can be given twice a day for ...
11/12/2024 - 8:28 am | View Link - People who are desperate to take Ozempic-like drugs are at 'risk,’ warns FDA
The rush for weight loss drugs like Wegovy and diabetes drugs like Ozempic (which is also used for weight loss) has drained Novo Nordisk’s supplies of each, meaning pharmacies have had to make up the ...
11/6/2024 - 11:30 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more